Full-Time

Medical Writer 1

Medical Practice

AXON

AXON

5,001-10,000 employees

Public-safety technology provider with TASER

No salary listed

London, UK

Hybrid

Hybrid role with on-site in London, UK.

Master's, PhD

Category
Content & Writing (1)
Required Skills
Word/Pages/Docs
Excel/Numbers/Sheets

Get referred to AXON

See people who can refer or advise you

Requirements
  • Some experience in a medical communications/pharmaceutical environment
  • Foundational understanding of therapy areas (preferably in diabetes and/or oncology)
  • Flawless attention to detail and excellent quality control skills
  • Strong scientific background, educated to a minimum degree level in life sciences (MSc/PhD advantageous)
  • A passion for communications and science
  • Strong organisational and time management skills
  • Excellent interpersonal and teamwork skills
  • A proactive, solutions-focused attitude
  • Strong IT skills, being comfortable with Microsoft packages such as Word, PowerPoint and Excel
  • Relevant writing experience in a medical communications/pharmaceutical role
  • Foundational understanding of healthcare and therapy areas
  • Excellent attention to detail and excellent quality control skills
  • Strong organizational, time management and interpersonal/team-work skills
  • Strong IT skills, being comfortable with ChatGPT or alternatives, Microsoft packages such as Word, PowerPoint and Excel
  • Strong IT skills, being comfortable with Microsoft packages such as Word, PowerPoint and Excel
Responsibilities
  • Accountability: the ability to process complex scientific data to produce clear, accurate, and high-quality editorial deliverables. Leverage your editorial capabilities to ensure strategic insights aligned with client expectations and maintain consistent quality.
  • Client Services: experience working in a medical communications/pharmaceutical agency. Engage in client meetings to refine project briefs, ensuring clarity and alignment with client expectations. Proactively assess client needs to exceed expectations and contribute to successful project outcomes.
  • Project Management: Must have worked on small- to medium-sized projects, ensuring adherence to high standards of quality, budget, and timeline. Monitor project progress and proactively flag any scope creep to ensure successful project delivery.
  • People Management: Required to foster professional development in a collaborative environment. Recognise and promote inclusivity, providing constructive feedback to encourage continuous improvement.

Axon provides public safety technology that combines hardware like TASER smart weapons, body-worn cameras, and in-car video systems with cloud-based software for evidence management and real-time situational awareness. Devices capture footage and data which is stored and analyzed in Axon’s SaaS platform through subscriptions, creating a continuous revenue stream alongside hardware sales. Its approach links physical tools with integrated software and analytics to create a connected ecosystem rather than standalone devices. Axon aims to improve public safety outcomes and accountability by giving agencies efficient, data-driven tools to protect lives.

Company Size

5,001-10,000

Company Stage

IPO

Headquarters

Scottsdale, Arizona

Founded

1993

Get referred to AXON

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Q2 2026 revenue rose 35% to $904 million, Axon's tenth straight over-30% quarter.
  • Annual recurring revenue reached $1.6 billion; net revenue retention hit 126%.
  • Axon Body Mini launched in June 2026 across the United States, Canada, Britain, Europe, Australia, and New Zealand.

What critics are saying

  • Axon faces consolidated antitrust class actions over VieVu and Taser pricing; damages claims continue.
  • Q2 software gross margin fell to 75.1% because memory costs and services mix compressed margins.
  • Trading around 200 times earnings, Axon needs flawless execution; any federal procurement slowdown hurts growth.

What makes AXON unique

  • Axon locks agencies into hardware, software, and long-term bookings; Q2 bookings hit $15.1 billion.
  • AI Era Plan, Records, Fusus, and Axon 911 expanded 70% in Q2 2026.
  • Dedrone and TASER 10 broaden Axon beyond cameras into counter-drone and conducted-energy weapons.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Disability Insurance

Life Insurance

Wellness Program

Hybrid Work Options

Paid Vacation

Sabbatical Leave

Dental Insurance

Employee Referral Bonus

Professional Development Budget

Growth & Insights and Company News

Headcount

6 month growth

20%

1 year growth

20%

2 year growth

20%
Yahoo Finance
Aug 10th, 2026
Axon stock rebounds 9.3% after 14.3% drop as market reassesses margin squeeze as growth investment

Axon Enterprise shares rebounded 9.3% on Friday following a 14.3% drop the previous day, with investors reassessing the company's second-quarter 2026 results. The initial sell-off came despite strong performance — revenue rose 35% year-over-year to $904 million, marking the tenth consecutive quarter of growth above 30%. The market's concern centred on compressed gross margins in the software and services segment, driven by rising memory costs and a higher mix of counter-drone hardware sales. Axon's Dedrone division surpassed $100 million in quarterly revenue, contributing to a 123% jump in Platform Solutions revenue. Management raised full-year revenue growth guidance to 32%–34% whilst maintaining its adjusted EBITDA margin outlook at 25.5%. The company expects near-term margin pressure from component costs and hardware scaling, with software revenue anticipated to follow hardware deployments. The third-quarter results will prove whether this margin squeeze represents temporary growing pains or a more persistent challenge.

Yahoo Finance
Aug 7th, 2026
Axon vs. Chewy: Police tech or pet supplies — which stock is the better buy in 2026?

Axon Enterprise and Chewy represent contrasting investment opportunities: rapid innovation versus predictable recurring revenue. Axon provides Taser devices, body cameras, and cloud-based software for law enforcement, expanding into fire, EMS, and commercial security markets. In FY 2025, Axon's revenue reached nearly $2.8 billion, up roughly a third year-over-year. Net income was nearly $125 million, down from $377 million in 2024, yielding a 5% net margin. The debt-to-equity ratio stands at roughly 0.6x. Chewy dominates digital pet supply through its Autoship subscription programme. FY 2025 revenue hit $12.6 billion, up 6% year-over-year. Net income reached $222.8 million, producing a 2% net margin. Chewy recently acquired Modern Animal and opened Chewy Vet Care clinics to deepen customer relationships.

Yahoo Finance
Aug 7th, 2026
Dow drops 464 points as Middle East tensions push oil prices up 3%, tech stocks falter

Wall Street closed lower on Thursday as investors awaited a permanent settlement of Middle East geopolitical conflicts and digested soft earnings from major companies. The Dow Jones Industrial Average fell 0.9%, or 464 points, to close at 53,885.10, ending a five-day winning streak. The tech-heavy Nasdaq Composite slipped 0.1% to finish at 26,363.44, whilst the S&P 500 declined 0.2% to 7,709.96. Geopolitical tensions heightened after an Iranian parliamentary committee reviewed a bill to bar US and Israeli ships from passing through the Strait of Hormuz. This development pushed crude oil prices higher, with West Texas Intermediate futures settling up 2.8% at $77.29 per barrel. Disappointing earnings weighed on sentiment. Axon Enterprise reported quarterly adjusted earnings of $1.88 per share, missing estimates, whilst Honeywell Aerospace's adjusted earnings of $1.87 per share fell short of the $2.07 consensus estimate.

Yahoo Finance
Aug 6th, 2026
Axon raises full-year outlook to 34% growth as software revenue hits $398M and counter-drone unit surpasses $100M

Axon Enterprise reported second-quarter revenue of $904 million, up 35% year-over-year, marking its tenth consecutive quarter of revenue growth above 30%. The company raised its full-year revenue growth outlook to 32%–34%, from a previous 30%–32%, while maintaining its adjusted EBITDA margin target of approximately 25.5%. Software and services revenue increased 36% to $398 million, with annual recurring revenue growing 39% to $1.6 billion. Net revenue retention reached 126%. Newer offerings including AI Era Plan, Records, Fusus and Axon 911 collectively grew roughly 70%, whilst the AI Era Plan alone grew nearly 700%. Axon's Dedrone business surpassed $100 million in quarterly revenue, contributing to a 123% increase in platform solutions revenue. The company noted potential opportunities in a $1.5 billion DHS counter-drone programme, though it hasn't estimated its likely share.

Yahoo Finance
Aug 5th, 2026
Axon reports Q2 revenue of $904M, up 35% YoY, raises full-year outlook to 32-34% growth

Axon reported Q2 2026 revenue of $904 million, up 35% year over year, marking its tenth consecutive quarter of growth exceeding 30%. The public safety technology company's annual recurring revenue grew 39% to $1.6 billion, with net revenue retention reaching 126%. Software and Services revenue increased 36% to $398 million, whilst Connected Devices revenue rose 35% to $507 million. Platform Solutions revenue surged 123% to $150 million, with Dedrone revenue surpassing $100 million. Future contracted bookings grew 41% year over year to $15.1 billion. Notable wins included two nine-figure agreements with major US cities and the largest individual TASER order in company history. Axon reported net income of $29 million and adjusted EBITDA of $242 million. The company raised its full-year revenue growth outlook to 32-34% whilst maintaining its adjusted EBITDA margin outlook at 25.5%.